STOCK TITAN

SciSparc (SPRC) director discloses shares, options and RSU awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

SciSparc Ltd. director Shrem Itschak filed an initial ownership report showing his equity position in the company. He directly holds 11,058 Ordinary Shares and a stock option to buy 6 Ordinary Shares at an exercise price of 21294.0000 per share, expiring on March 1, 2028.

The filing also notes restricted share units. These include 10,000 Ordinary Shares in RSUs vesting in equal quarterly installments of 1,250 shares beginning on March 18, 2026, and 396 Ordinary Shares in RSUs vesting 50 shares quarterly beginning on September 30, 2024. Each RSU converts into one Ordinary Share when vested.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Shrem Itschak

(Last)(First)(Middle)
20 RAUL WALLENBERG STREET
TOWER A, TEL AVIV, ISRAEL

(Street)
TEL AVIV6971916

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
SciSparc Ltd. [ SPRC ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares11,058(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (right to buy)03/01/202203/01/2028Ordinary Shares6(2)$21,294D
Explanation of Responses:
1. Includes (i) 10,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal quarterly installments of 1,250 Ordinary Shares beginning on March 18, 2026; and (ii) 396 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 50 Ordinary Shares beginning on September 30, 2024. Each RSU represents the right to receive one Ordinary Share.
2. Fully vested on April 21, 2024.
/s/ Itschak Shrem03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does SciSparc (SPRC) director Shrem Itschak report owning in this Form 3?

Director Shrem Itschak reports direct ownership of 11,058 Ordinary Shares of SciSparc Ltd. He also reports a stock option for 6 Ordinary Shares and multiple restricted share unit grants that may convert into additional shares as they vest over time.

What stock option position does Shrem Itschak hold in SciSparc (SPRC)?

He holds a stock option to buy 6 Ordinary Shares of SciSparc at an exercise price of 21294.0000 per share. This option became fully vested on April 21, 2024 and is scheduled to expire on March 1, 2028.

What restricted share units (RSUs) are disclosed for Shrem Itschak in SciSparc (SPRC)?

The filing discloses 10,000 Ordinary Shares in RSUs vesting quarterly in 1,250-share installments beginning March 18, 2026, plus 396 Ordinary Shares in RSUs vesting 50 shares quarterly beginning September 30, 2024. Each RSU entitles the holder to receive one Ordinary Share when vested.

Is this SciSparc (SPRC) Form 3 a buy or sell transaction by Shrem Itschak?

This Form 3 is an initial statement of beneficial ownership, not a buy or sell report. It lists the director’s existing holdings in Ordinary Shares, stock options, and RSUs as of the reporting date, without showing any new purchase or sale transactions.

How long do Shrem Itschak’s SciSparc (SPRC) stock options remain exercisable?

The disclosed stock option relating to 6 Ordinary Shares was fully vested by April 21, 2024 and carries an expiration date of March 1, 2028. After that expiration date, any unexercised portion would no longer be available to exercise.

When do the RSUs reported by SciSparc (SPRC) director Shrem Itschak start vesting?

Two RSU schedules are reported. 396 Ordinary Shares in RSUs begin vesting in 50-share quarterly installments on September 30, 2024. Another 10,000 Ordinary Shares in RSUs vest in 1,250-share quarterly installments beginning on March 18, 2026, each RSU delivering one Ordinary Share.
Scisparc

NASDAQ:SPRC

View SPRC Stock Overview

SPRC Rankings

SPRC Latest News

SPRC Latest SEC Filings

SPRC Stock Data

2.44M
421.36k
Biotechnology
Healthcare
Link
Israel
Tel Aviv-Yafo